Brief: 10X Genomics Wins Patent Infringement Verdict Against Parse Biosciences
28/08/2026 19:43
BRIEF-10X Genomics Wins Patent Infringement Verdict Against Parse Biosciences Aug 28 (Reuters) - 10x Genomics TXG.O:
10X GENOMICS WINS PATENT INFRINGEMENT VERDICT AGAINST PARSE BIOSCIENCES
10X GENOMICS - JURY FINDS PARSE BIOSCIENCES WILLFULLY INFRINGED THREE SCALE BIOSCIENCES PATENTS
10X GENOMICS - JURY AWARDS CO OVER $4.80 MILLION IN DAMAGES FOR INFRINGING SALES FEB 2021-JUNE 30, 2026
10X GENOMICS - TO SEEK ENHANCED DAMAGES AND PERMANENT INJUNCTION AGAINST PARSE IN U.S.
Source text: ID:nPn2lXqdya
Further company coverage: [TXG.O QIA.DE]
((Reuters.Briefs@thomsonreuters.com;))
Recent news on 10x Genomics
See all newsBrief: 10X Genomics Announces New Collaboration To Advance Single Cell And Spatial Applications Across Solid Tumors And Blood Cancers
U.S. RESEARCH ROUNDUP-Autodesk, Hubspot, Oracle
Delaware jury finds Parse infringed three genetic-sequencing patents (updated)
Qiagen owes 10x, Roche $4.8 million for infringing patents, U.S. jury says
Brief: 10X Genomics Wins Patent Infringement Verdict Against Parse Biosciences